181 related articles for article (PubMed ID: 33963375)
1. A Novel Mouse Model for SNP in Steroid Receptor Co-Activator-1 Reveals Role in Bone Density and Breast Cancer Metastasis.
Watters RJ; Verdelis K; Lucas PC; Jiang S; Chen Y; Lu F; Martin BM; Lukashova L; Pecar G; Morales-Restrepo A; Hankins M; Zhu L; Mittwede P; Hartmaier RJ; Alexander PG; Tseng GC; Weiss KR; Galson DL; Lee AV; Lee B; Oesterreich S
Endocrinology; 2021 Aug; 162(8):. PubMed ID: 33963375
[TBL] [Abstract][Full Text] [Related]
2. A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone.
Hartmaier RJ; Richter AS; Gillihan RM; Sallit JZ; McGuire SE; Wang J; Lee AV; Osborne CK; O'Malley BW; Brown PH; Xu J; Skaar TC; Philips S; Rae JM; Azzouz F; Li L; Hayden J; Henry NL; Nguyen AT; Stearns V; Hayes DF; Flockhart DA; Oesterreich S
Mol Endocrinol; 2012 Feb; 26(2):220-7. PubMed ID: 22174377
[TBL] [Abstract][Full Text] [Related]
3. RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model.
Canon J; Bryant R; Roudier M; Branstetter DG; Dougall WC
Breast Cancer Res Treat; 2012 Oct; 135(3):771-80. PubMed ID: 22926264
[TBL] [Abstract][Full Text] [Related]
4. The Src kinase pathway promotes tamoxifen agonist action in Ishikawa endometrial cells through phosphorylation-dependent stabilization of estrogen receptor (alpha) promoter interaction and elevated steroid receptor coactivator 1 activity.
Shah YM; Rowan BG
Mol Endocrinol; 2005 Mar; 19(3):732-48. PubMed ID: 15528270
[TBL] [Abstract][Full Text] [Related]
5. Steroid receptor coactivator 1 deficiency increases MMTV-neu mediated tumor latency and differentiation specific gene expression, decreases metastasis, and inhibits response to PPAR ligands.
Han JS; Crowe DL
BMC Cancer; 2010 Nov; 10():629. PubMed ID: 21080969
[TBL] [Abstract][Full Text] [Related]
6. Steroid receptor coactivator-1 upregulates integrin α₅ expression to promote breast cancer cell adhesion and migration.
Qin L; Chen X; Wu Y; Feng Z; He T; Wang L; Liao L; Xu J
Cancer Res; 2011 Mar; 71(5):1742-51. PubMed ID: 21343398
[TBL] [Abstract][Full Text] [Related]
7. Selective estrogen receptor modulators inhibit growth and progression of premalignant lesions in a mouse model of ductal carcinoma in situ.
Namba R; Young LJ; Maglione JE; McGoldrick ET; Liu S; Wurz GT; DeGregorio MW; Borowsky AD; MacLeod CL; Cardiff RD; Gregg JP
Breast Cancer Res; 2005; 7(6):R881-9. PubMed ID: 16280035
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants for the tissue specificity of SERMs.
Shang Y; Brown M
Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541
[TBL] [Abstract][Full Text] [Related]
9. Distinctive functions of p160 steroid receptor coactivators in proliferation of an estrogen-independent, tamoxifen-resistant breast cancer cell line.
Karmakar S; Foster EA; Blackmore JK; Smith CL
Endocr Relat Cancer; 2011 Feb; 18(1):113-27. PubMed ID: 21059860
[TBL] [Abstract][Full Text] [Related]
10. The steroid receptor coactivator-1 regulates twist expression and promotes breast cancer metastasis.
Qin L; Liu Z; Chen H; Xu J
Cancer Res; 2009 May; 69(9):3819-27. PubMed ID: 19383905
[TBL] [Abstract][Full Text] [Related]
11. Role of estrogen receptors and Src signaling in mechanisms of bone metastasis by estrogen receptor positive breast cancers.
Chiu JH; Wen CS; Wang JY; Hsu CY; Tsai YF; Hung SC; Tseng LM; Shyr YM
J Transl Med; 2017 May; 15(1):97. PubMed ID: 28472954
[TBL] [Abstract][Full Text] [Related]
12. NCOA1 Directly Targets M-CSF1 Expression to Promote Breast Cancer Metastasis.
Qin L; Wu YL; Toneff MJ; Li D; Liao L; Gao X; Bane FT; Tien JC; Xu Y; Feng Z; Yang Z; Xu Y; Theissen SM; Li Y; Young L; Xu J
Cancer Res; 2014 Jul; 74(13):3477-88. PubMed ID: 24769444
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of epithelial-mesenchymal transition phenotype in the tamoxifen-resistant breast cancer cell: a new role for G protein-coupled estrogen receptor in mediating tamoxifen resistance through cancer-associated fibroblast-derived fibronectin and β1-integrin signaling pathway in tumor cells.
Yuan J; Liu M; Yang L; Tu G; Zhu Q; Chen M; Cheng H; Luo H; Fu W; Li Z; Yang G
Breast Cancer Res; 2015 May; 17(1):69. PubMed ID: 25990368
[TBL] [Abstract][Full Text] [Related]
14. Cytoplasmic ERα and NFκB Promote Cell Survival in Mouse Mammary Cancer Cell Lines.
Smart E; Alejo LH; Frasor J
Horm Cancer; 2020 Apr; 11(2):76-86. PubMed ID: 32008217
[TBL] [Abstract][Full Text] [Related]
15. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
Chen B; Gajdos C; Dardes R; Kidwai N; Johnston SR; Dowsett M; Jordan VC
Int J Oncol; 2005 Aug; 27(2):327-35. PubMed ID: 16010412
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous bone metastases in a preclinical orthotopic model of invasive lobular carcinoma; the effect of pharmacological targeting TGFβ receptor I kinase.
Buijs JT; Matula KM; Cheung H; Kruithof-de Julio M; van der Mark MH; Snoeks TJ; Cohen R; Corver WE; Mohammad KS; Jonkers J; Guise TA; van der Pluijm G
J Pathol; 2015 Apr; 235(5):745-59. PubMed ID: 25421310
[TBL] [Abstract][Full Text] [Related]
17. Steroid receptor coactivator 3 is a key modulator of regulatory T cell-mediated tumor evasion.
Han SJ; Jain P; Gilad Y; Xia Y; Sung N; Park MJ; Dean AM; Lanz RB; Xu J; Dacso CC; Lonard DM; O'Malley BW
Proc Natl Acad Sci U S A; 2023 Jun; 120(23):e2221707120. PubMed ID: 37253006
[TBL] [Abstract][Full Text] [Related]
18. Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen.
Kressler D; Hock MB; Kralli A
J Biol Chem; 2007 Sep; 282(37):26897-26907. PubMed ID: 17631495
[TBL] [Abstract][Full Text] [Related]
19. C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis.
Myoui A; Nishimura R; Williams PJ; Hiraga T; Tamura D; Michigami T; Mundy GR; Yoneda T
Cancer Res; 2003 Aug; 63(16):5028-33. PubMed ID: 12941830
[TBL] [Abstract][Full Text] [Related]
20. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
Moi LL; Flågeng MH; Gjerde J; Madsen A; Røst TH; Gudbrandsen OA; Lien EA; Mellgren G
BMC Cancer; 2012 Jun; 12():247. PubMed ID: 22703232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
